Streetbeat News

Analyst Ratings

SAIA

10 analysts have rated Saia (NASDAQ:SAIA) over the past 3 months, with an average price target of $308.1, implying an upside from the current price of $304.295. The current average has increased by 6.28% from the previous average price target of $289.89.

Portfolio Pulse from Benzinga Insights

June 12, 2023 | 6:01 pm

NXGN

In the last 3 months, 6 analysts have provided 12-month price targets for NextGen Healthcare (NASDAQ:NXGN), with an average target of $20.33, down 6.53% from the previous average of $21.75.

Portfolio Pulse from Benzinga Insights

June 12, 2023 | 6:00 pm

SPOT

Analysts have provided various ratings for Spotify Technology (NYSE:SPOT) within the last quarter, with an average price target of $155.24, implying an upside from the current price of $149.55. The average price target has increased by 12.97% over the past month.

Portfolio Pulse from Benzinga Insights

June 12, 2023 | 6:00 pm

DAVA

Susquehanna analyst James E Friedman has reiterated a Positive rating on Endava Plc (NYSE:DAVA) but lowered the price target from $104.00 to $100.00 due to industry uncertainty. The analyst trimmed September estimates and noted a decline in Endava's current revenue per workday growth. However, the company is expected to benefit from technological change and the DEK acquisition.

Portfolio Pulse from Nabaparna Bhattacharya

June 12, 2023 | 5:57 pm

EPAM

KeyBanc Capital Market analyst Thomas Blakey downgraded EPAM Systems, Inc. (NYSE:EPAM) to Sector Weight from Overweight, citing pricing headwinds, increased caution in spending from clients, and lower pipeline conversions. KeyBanc reduced FY23 and FY24 revenue guidance for the company.

Portfolio Pulse from Nabaparna Bhattacharya

June 12, 2023 | 5:51 pm

CELH

Celsius Holdings shares are trading higher following a note from Evercore ISI highlighting strength in energy drink growth trends.

Portfolio Pulse from Benzinga Newsdesk

June 12, 2023 | 5:47 pm

CFG

Citizens Financial Group shares are trading lower amid weakness in financials. Citigroup maintained a Neutral rating on the stock and lowered its price target from $34 to $31.

Portfolio Pulse from Benzinga Newsdesk

June 12, 2023 | 5:40 pm

IMGN

ImmunoGen shares are trading higher after Barclays maintained an Overweight rating on the stock and raised its price target from $9 to $20.

Portfolio Pulse from Benzinga Newsdesk

June 12, 2023 | 5:26 pm

NNWWF

RBC Capital analyst Sabahat Khan maintains a Sector Perform rating on North West Co (OTC:NNWWF) and lowers the price target from C$38 to C$36.

Portfolio Pulse from Benzinga Newsdesk

June 12, 2023 | 5:21 pm

CGC

CIBC analyst John Zamparo maintains an Underperformer rating on Canopy Growth (NASDAQ:CGC) and lowers the price target from C$1.75 to C$0.5.

Portfolio Pulse from Benzinga Newsdesk

June 12, 2023 | 5:18 pm